Innovative research led by a team of investigators from Dartmouth’s Geisel School of Medine—in collaboration with national and local organizations across the U.S.—is showing promise in helping to improve the health and wellness of emergency medical services clinicians.
In his annual State of the Medical School address, Dean Duane Compton, PhD, delivered an overview of the Geisel School of Medicine’s achievements over the past year. Dean Compton expressed his excitement at the collective accomplishments within the school’s mission areas.
A research group led by investigators at Dartmouth and Massachusetts General Hospital, and including seven other institutions across the U.S., have received a five-year, $13 million funding award from the Patient-Centered Outcomes Research Institute (PCORI). Their project will test the effectiveness of video as a communication tool during patient visits for people living with Amyotrophic Lateral Sclerosis (ALS) and their caregivers.
The new Biological Mass Spectrometry and Proteomics Shared Resource at the Geisel School of Medicine provides investigators across Dartmouth’s research community new tools and resources for studying the molecular components of the human cell. This capability helps researchers to make disease diagnoses, identify new biomarkers and drug targets, and gain a deeper understanding of biological processes and the causes of diseases such as cancer.
Very early exposure to even a very small dose of herpes simplex virus (HSV) in infant mice can lead to cognitive decline later in life, according to findings from a new Dartmouth-led study, published in the journal PLoS Pathogens. This is significant because of emerging data in human studies showing an association between HSV and Alzheimer’s disease in humans.
Findings from a new Dartmouth-led study, published in the journal mBio, highlight key differences in the gut microbiome of infants with cystic fibrosis (CF) compared to that of healthy infants, and how these alterations may adversely affect their health.
Geisel researcher Paul Barr, PhD, MSc, discusses his work to improve patient outcomes through the development of new tools to enhance communications between patients and their healthcare providers.
Findings from a new study, conducted by a team of researchers at Dartmouth’s Geisel School of Medicine and collaborating institutions and published in the journal e-clinical Medicine, a member of the Lancet family of journals, show beneficial effects on functionally important respiratory symptoms when persons who smoke switch completely to e-cigarettes.
On October 29, nearly 200 members of the local, national, and international digital health community—including researchers, clinicians, healthcare administrators, payors, investors, experts from government and industry, and students and trainees—gathered for a daylong meeting at Dartmouth College to discuss the expanding field of digital therapeutics.
The Center for Technology and Behavioral Health (CTBH) at the Geisel School of Medicine at Dartmouth has announced an innovative collaboration with Boehringer Ingelheim with the goal of advancing prescription digital therapeutics that specifically target serious mental illness.
Upcoming EventsThis page may link to PDF files. Use this link to download Adobe Reader if needed.